Estradiol Patch Shortage: Why FDA and Pharmacists Disagree

Last checked: September 17, 2026, against the ASHP bulletin updated August 12, 2026 and the FDA statement dated September 3, 2026.

If you have called three pharmacies this week and still have no patch, you are not imagining the estrogen patch shortage. Two groups that track US drug supply just describe it differently. Here is what each says, which patches are affected, and what to do while you wait.

This article provides general information about medication management and is not a substitute for professional medical advice. Consult your doctor or pharmacist for advice specific to your medications.

Is There an Estradiol Patch Shortage Right Now?

According to pharmacists, yes. The ASHP drug shortage bulletin for estradiol transdermal systems was created on January 30, 2026. Its latest update, on August 12, lists 17 affected packages from Sandoz, Amneal, Noven, Viatris and Zydus.

The FDA describes it differently. In its September 3, 2026 update, the agency says patients are having "difficulty readily accessing their usual estradiol transdermal patches due to increased demand." It also says patches "remain available," though "availability of certain products or brands may vary by pharmacy or location." The page never uses the word "shortage."

Estradiol patches are also not in the FDA's own drug shortage database. Some news stories, like this one from Stateline, have described the September 3 update as the FDA acknowledging a shortage. That is the reporters' wording, not the FDA's.

Why Does the FDA Say Estradiol Patches Are Still Available?

Because the FDA and ASHP use different rules for what counts as a shortage. In 2014 the two groups laid out those rules in a side-by-side comparison of FDA and ASHP shortage lists.

That last row explains most of the confusion. Under ASHP's rules, one missing strength from one company keeps the drug listed. ASHP's shortage FAQ says products stay listed "despite intermittent or partially restored availability." That includes products on allocation. The FDA tracks shortages at the national level. So both can be true. Some patches still reach pharmacies, but your exact brand and strength may not.

Why Is There an Estrogen Patch Shortage?

The FDA points to demand. Its update says demand rose after a November 2025 FDA action. The agency asked makers to remove boxed warnings about "a probable risk of breast cancer, cardiovascular disease, and probable dementia" from menopausal hormone therapy labels. More women have also been seeking treatment for menopause symptoms. The FDA still urges patients to talk with their providers "about the potential benefits and risks of menopausal hormone therapy."

The companies themselves have said less. In the ASHP bulletin, only Noven gives a reason, which is increased demand. Amneal, Sandoz, Viatris and Zydus each "did not provide a reason."

Supply has grown, but not enough to clear the ASHP list. The FDA says supply "has nearly doubled" over the last year. Bigger factory expansions "may take more time because transdermal patches require specialized equipment and manufacturing processes."

When Will the Estradiol Patch Shortage End?

Nobody has given a date. Here is what each company told ASHP in the August 12 update:

• Amneal "cannot estimate a release date" for the two Dotti strengths on back order.
• Sandoz gives the same answer for two of its strengths and has the rest on allocation.
• Noven is on intermittent back order "with weekly releases."
• Viatris is releasing supplies "as they become available."
• Zydus has all its affected strengths on allocation.

The FDA says it is working with "all six manufacturers." It is also speeding up reviews that could raise supply. It does not say when that will be enough. We will update this page when either group posts news.

Which Estradiol Patch Brands and Strengths Are Affected?

This table follows the ASHP bulletin as of August 12, 2026. Strengths are listed only so you can match your own box. They are not a suggestion to change doses. The schedule column comes from each product's FDA label.

Schedules are from the labels for Climara, Sandoz, Mylan once-weekly, Dotti, Lyllana, Noven, Zydus and Mylan twice-weekly. The bulletin also notes that the brand Minivelle has been discontinued.

What If It's Not a Shortage, Just Your Pharmacy?

Sometimes the problem is local. The FDA's shortage FAQ says local supply problems are usually "temporary" and often involve distribution issues. Those clear up "when the pharmacy is able to reorder from their distributor." The FDA suggests you "check multiple stores or pharmacies."

Before assuming your patch is gone, ask your pharmacist two things. Is my exact product back-ordered from the maker, or just not in your store today? And when is your next delivery? Our guide on what to do when the pharmacy is out of your medication walks through calling around and moving a prescription.

What to Do If Your Estradiol Patch Is Out of Stock

The FDA's own advice to patients comes down to four steps. Here they are, plus what to ask.

1. Ask your pharmacist about other makers. The FDA says your pharmacist "may be able to help locate another available FDA-approved estradiol transdermal patch that can be substituted for your current product, when appropriate." Ask about the same strength with the same change schedule first.
2. Check back, and check other pharmacies. Availability "may change as additional products reach pharmacies," the FDA says, so call ahead before you transfer.
3. Talk to your prescriber if nothing matches. A different brand, schedule or form is their call. The FDA says your provider can discuss "whether another estradiol product may be appropriate for you." Our comparisons of estrogen gel vs the patch and the estradiol patch vs the pill can help you prepare questions.
4. Do not stop or change on your own. The FDA is direct: "Do not stop or change your medication without talking with your healthcare provider." If you also take progesterone as part of hormone therapy, keep taking it as prescribed and ask your prescriber before changing it. Our page on a missed dose of progesterone covers why that part matters.

You can also tell the FDA. Its shortage FAQ says patients may report a potential shortage through its online public portal.

Does Switching Estradiol Patch Brands Change Your Schedule?

It can, and this is easy to miss. As the table above shows, some patches are changed once a week and others twice a week. The Climara label says to change it "1 time each week or every 7 days." The Dotti label says "2 times a week or every 3 to 4 days."

So if your pharmacy fills a different brand, check the box before the first change. Moving between twice-weekly and once-weekly patches moves your change days too. MedlinePlus says to "always apply your transdermal patch on the same day(s) of the week every week." After a switch, those are new days. Our estradiol patch schedule guide shows how to pick and lock them in.

If a change day slips after a switch, see what to do if you forgot to change your estradiol patch. If a new brand does not stick as well, see what to do when an estradiol patch falls off.

How Pillo Helps

A shortage adds new things to remember, like new change days after a brand switch. Pillo's persistent alarms keep going until you respond, so a new Thursday change day does not slip past in week one. You can set once-weekly or twice-weekly schedules on the exact days your label calls for.

Pillo's refill reminders can alert you before you run out, which leaves time to call around. You can also add a dose note with the brand and maker of the box you picked up, so you know which schedule you are on.

Download Pillo on Google Play

FAQ

Is there still an estradiol patch shortage in 2026?

As of the ASHP bulletin updated August 12, 2026, yes. ASHP lists 17 estradiol patch packages from five companies as back-ordered or on allocation. The FDA has not added estradiol patches to its shortage database and said on September 3, 2026 that patches "remain available," though brands may vary by pharmacy.

Why does the FDA say there is no estradiol patch shortage?

The FDA's September 3 update does not use the word "shortage." It said patches "remain available" and that access varies by pharmacy. The FDA treats a shortage as over when one or more makers can meet national demand. ASHP keeps a drug listed until every maker has every strength back, so the two lists can disagree.

Which estradiol patch brands are available right now?

In the August 12, 2026 ASHP bulletin, Climara (Bayer) and Viatris once-weekly patches were listed as available in all strengths. So were Lyllana (Amneal), several Dotti strengths and most Viatris twice-weekly packages. Stock still varies by pharmacy, so ask your pharmacist to check.

Can I switch to a different estradiol patch brand?

Your pharmacist may be able to substitute another FDA-approved estradiol patch when appropriate, according to the FDA. Check whether the new brand uses a different change schedule, once or twice a week. Talk to your prescriber about any change in strength, schedule or form.

What happens if I can't get my estrogen patch?

Call your prescriber before you run out, not after. The FDA says not to stop or change your medication without talking to your healthcare provider, and to check back with your pharmacy because supply may change. If you take progesterone too, keep taking it as prescribed unless your prescriber says otherwise.

Is there an estradiol patch shortage at CVS?

The ASHP bulletin and the FDA update list manufacturers, not pharmacy chains, and neither one names CVS. The FDA says availability "may vary by pharmacy or location." Ask the pharmacist which maker they can order, then compare it with the table above.

Should I cut a higher-strength patch in half?

Ask your prescriber or pharmacist before cutting an estradiol patch in half. The ASHP bulletin warns that reservoir patches "should never be cut" and that cutting a matrix patch "may result in uneven dose release."